AI assistant
REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2017
May 26, 2017
29977_dirs_2017-05-26_36949758-83aa-44a1-97c9-326fb2ec3bdd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2017-05-25
Reporting Person: VAGELOS P ROY (Director, Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-01-03 | Common Stock | G | 571 | $0.0 | Disposed | 151254 | Indirect |
| 2017-04-03 | Common Stock | G | 547 | $0.0 | Disposed | 150707 | Indirect |
| 2017-05-25 | Common Stock | S | 3510 | $457.58 | Disposed | 89437 | Indirect |
| 2017-05-25 | Common Stock | S | 4985 | $458.35 | Disposed | 84452 | Indirect |
| 2017-05-25 | Common Stock | S | 800 | $459.24 | Disposed | 83652 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 414156 | Direct |
| Common Stock | 2300 | Indirect |
| Common Stock | 1203 | Indirect |
Footnotes
F1: Represents volume-weighted average price of sales of 3,510 shares of Company stock on May 25, 2017 at prices ranging from $457.05 to $457.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 25, 2017 at each separate price.
F2: Represents volume-weighted average price of sales of 4,985 shares of Company stock on May 25, 2017 at prices ranging from $458.00 to $458.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 25, 2017 at each separate price.
F3: Represents volume-weighted average price of sales of 800 shares of Company stock on May 25, 2017 at prices ranging from $459.01 to $459.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 25, 2017 at each separate price.
F4: By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.